Monoaminergic regulation of striatal cannabinoid CB1 receptor expression - Implications for the treatment of Parkinson's disease.

被引：0
|
作者：
Silverdale, MA [1 ]
McGuire, S [1 ]
McInnes, A [1 ]
Crossman, AR [1 ]
Brotchie, JM [1 ]
机构：
[1] Manchester Movement Disorders Lab, Manchester, Lancs, England
来源：
EUROPEAN JOURNAL OF NEUROSCIENCE | 2000年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [31] Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats
    Zeng, BY
    Dass, B
    Owen, A
    Rose, S
    Cannizzaro, C
    Tel, BC
    Jenner, P
    NEUROSCIENCE LETTERS, 1999, 276 (02) : 71 - 74
  • [32] Neuroprotective Potential of Adenosine A2A and Cannabinoid CB1 Receptor Antagonists in an Animal Model of Parkinson Disease
    Cerri, Silvia
    Levandis, Giovanna
    Ambrosi, Giulia
    Montepeloso, Elena
    Antoninetti, Gian Filippo
    Franco, Rafael
    Lanciego, Jose Luis
    Baqi, Younis
    Mueller, Christa E.
    Pinna, Annalisa
    Blandini, Fabio
    Armentero, Marie Therese
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (05): : 414 - 424
  • [33] Expression and biological effects of CB1 cannabinoid receptor in rat parotid gland
    Busch, L
    Sterin-Borda, L
    Borda, E
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (09) : 1767 - 1774
  • [34] Dysregulation of Cannabinoid CB1 Receptor Expression in Subcutaneous Adipocytes of Obese Individuals
    Lee, Yong-Ho
    Tharp, William G.
    Dixon, Anne E.
    Spaulding, Laurie
    Trost, Susanne
    Nair, Saraswathy
    Permana, Paska A.
    Pratley, Richard E.
    ANIMAL CELLS AND SYSTEMS, 2009, 13 (04) : 371 - 379
  • [35] Expression of functionally active cannabinoid receptor CB1 in the human prostate gland
    Ruiz-Llorente, L
    Sánchez, MG
    Carmena, MJ
    Prieto, JC
    Sánchez-Chapado, M
    Izquierdo, A
    Díaz-Laviada, I
    PROSTATE, 2003, 54 (02): : 95 - 102
  • [36] Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
    Smith, Tricia H.
    Blume, Lawrence C.
    Straiker, Alex
    Cox, Jordan O.
    David, Bethany G.
    Mcvoy, Julie R. Secor
    Sayers, Katherine W.
    Poklis, Justin L.
    Abdullah, Rehab A.
    Egertova, Michaela
    Chen, Ching-Kang
    Mackie, Ken
    Elphick, Maurice R.
    Howlett, Allyn C.
    Selley, Dana E.
    MOLECULAR PHARMACOLOGY, 2015, 87 (04) : 747 - 765
  • [37] Role of cannabinoid CB2 receptor in Parkinson's disease
    Navarrete Rueda, F.
    Garcia-Gutierrez, M. S.
    Aracil-Fernandez, A.
    Molina-Arjona, J. A.
    Leiva-Santana, C.
    Manzanares, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S646 - S647
  • [38] Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex
    Lee, Jasinda H.
    Agacinski, Grzegorz
    Williams, Jonathan H.
    Wilcock, Gordon K.
    Esiri, Margaret M.
    Francis, Paul T.
    Wong, Peter T-H
    Chen, Christopher P.
    Lai, Mitchell K.
    NEUROCHEMISTRY INTERNATIONAL, 2010, 57 (08) : 985 - 989
  • [39] Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a G(s) linkage to the CB1 receptor
    Glass, M
    Felder, CC
    JOURNAL OF NEUROSCIENCE, 1997, 17 (14): : 5327 - 5333
  • [40] CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
    Teixeira-Clerc, Fatima
    Julien, Boris
    Grenard, Pascale
    Van Nhieu, Jeanne Tran
    Deveaux, Vanessa
    Li, Liying
    Serriere-Lanneau, Valerie
    Ledent, Catherine
    Mallat, Ariane
    Lotersztajn, Sophie
    NATURE MEDICINE, 2006, 12 (06) : 671 - 676
12345